A premixed insulin analog injection combining rapid-acting and intermediate-acting insulin, designed to control blood glucose levels in patients with diabetes mellitus. It provides both immediate and prolonged glucose-lowering effects, helping to manage postprandial spikes and maintain basal insulin coverage.

Indications:
- Management of Type 1 Diabetes Mellitus.
- Management of Type 2 Diabetes Mellitus when insulin is required.
- Control of postprandial hyperglycemia.
- Maintenance of basal insulin needs.
- Patients requiring insulin therapy with simplified dosing compared to separate injections.

Main Active Ingredients:
- Insulin Lispro (25%).
- Insulin Lispro Protamine Suspension (75%).

Precautions:
- For subcutaneous injection only; do not administer intravenously.
- Rotate injection sites to prevent lipodystrophy or skin thickening.
- Monitor blood glucose regularly to avoid hypoglycemia or hyperglycemia.
- Use with caution in patients with renal or hepatic impairment.
- Adjust dose during illness, stress, surgery, or changes in diet/activity.
- Consult a doctor before use in pregnancy or breastfeeding.
- Do not share pens between patients (risk of cross-infection).
- Store refrigerated; do not freeze.

Possible Side Effects:
- Hypoglycemia.
- Local injection site reactions (redness, swelling, itching).
- Lipodystrophy.
- Weight gain.
- Allergic reactions.
- Rash.
- Edema.

Drug-Drug Interactions:
- Oral hypoglycemics.
- ACE inhibitors.
- Salicylates.
- SSRIs.
- Corticosteroids.
- Diuretics.
- Thyroid hormones.
- Sympathomimetics.
- Beta-blockers.
- Alcohol.